BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hulten KG, Lamberth LB, Kalfus IN, Graham DY. National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial. Gastroenterology 2021;161:342-344.e1. [PMID: 33798524 DOI: 10.1053/j.gastro.2021.03.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, He C, Zhu Y. Treatment of refractory Helicobacter pylori infection: A new challenge for clinicians. Front Microbiol 2022;13:998240. [DOI: 10.3389/fmicb.2022.998240] [Reference Citation Analysis]
2 Chey WD, Mégraud F, Laine L, López LJ, Hunt BJ, Howden CW. Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial. Gastroenterology 2022;163:608-19. [PMID: 35679950 DOI: 10.1053/j.gastro.2022.05.055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
3 Shatila M, Thomas AS. Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection. JCM 2022;11:5086. [DOI: 10.3390/jcm11175086] [Reference Citation Analysis]
4 Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF. Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2022;117:1221-30. [PMID: 35509128 DOI: 10.14309/ajg.0000000000001828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Munir M, LeMaitre B, Lobo Z, Psevdos G. A 15-year review of Helicobacter pylori screening and treatment among United States Veterans. Helicobacter 2022;:e12919. [PMID: 35899999 DOI: 10.1111/hel.12919] [Reference Citation Analysis]
6 Saif N, Jensen N, Farrar E, Blackstone S, Hauck FR. Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States. Helicobacter 2022;:e12894. [PMID: 35484785 DOI: 10.1111/hel.12894] [Reference Citation Analysis]
7 Pettengill MA. Clinical Microbiology in 2021: My Favorite Studies about Everything Except My Least Favorite Virus. Clinical Microbiology Newsletter 2022;44:73-80. [DOI: 10.1016/j.clinmicnews.2022.04.003] [Reference Citation Analysis]
8 Shakir SM, Otiso J, Keller G, Heule HV, Osborn LJ, Cole N, Schuetz AN, Richter SS, Couturier MR, Lainhart W. Multicenter Evaluation of a Gradient Diffusion Method for Antimicrobial Susceptibility Testing of Helicobacter pylori. Microbiol Spectr. [DOI: 10.1128/spectrum.02111-21] [Reference Citation Analysis]
9 Azad KN, Realegeno SE, Kagan RM, Schwab DA, Batterman HJ, Marlowe EM. An Easily Digestible Review of Helicobacter pylori Diagnostics. Clinical Microbiology Newsletter 2022;44:51-61. [DOI: 10.1016/j.clinmicnews.2022.03.001] [Reference Citation Analysis]
10 Hulten KG, Genta RM, Kalfus IN, Zhou Y, Zhang H, Graham DY. Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies. Gastroenterology 2021;161:1433-1442.e2. [PMID: 34293298 DOI: 10.1053/j.gastro.2021.07.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
11 Bujanda L, Nyssen OP, Vaira D, Saracino IM, Fiorini G, Lerang F, Georgopoulos S, Tepes B, Heluwaert F, Gasbarrini A, Rokkas T, Bordin D, Smith S, Lamy V, Caldas M, Resina E, Muñoz R, Cosme Á, Puig I, Megraud F, O'Morain C, Gisbert JP; The Hp-EuReg Investigators. Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013-2020: Results of the European Registry on H. pylori Management (Hp-EuReg). Antibiotics (Basel) 2021;10:1058. [PMID: 34572640 DOI: 10.3390/antibiotics10091058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]